Editas Medicine Inc
Change company Symbol lookup
Select an option...
EDIT Editas Medicine Inc
BOSC BOS Better Online Solutions Ltd
BORR Borr Drilling Ltd
BOOT Boot Barn Holdings Inc
EPD Enterprise Products Partners LP
$JSEMET EMIX Smaller Europe Metal Production
CUB Cubic Corp
FB Facebook Inc
NWVCF Enwave Corp
MMM 3M Co
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Editas Medicine, Inc. is a genome editing company. It is engaged in treating patients with genetically defined diseases by correcting their disease-causing genes. It operates through developing and commercializing genome editing technology segment. It is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or CRISPR from Prevotella and Francisella 1 (Cpf1), bound to a guide RNA molecule designed to recognize a particular deoxyribonucleic acid (DNA) sequence. Its platform consists of four components: nuclease engineering, delivery, control and specificity, and directed editing. Its programs include Eye Diseases, Engineered T Cell Therapies for Immuno-Oncology and additional research programs. It is developing a genome editing therapeutic for Leber Congenital Amaurosis type 10 (LCA10).

Closing Price
$76.14
Day's Change
0.22 (0.29%)
Bid
--
Ask
--
B/A Size
--
Day's High
83.95
Day's Low
76.04
Volume
(Heavy Day)
Volume:
4,305,580

10-day average volume:
2,844,537
4,305,580
  • Prev Close
    75.92
  • Today's Open
    76.49
  • Day's Range
    76.04-83.95
  • Avg Vol (10-day)
    2.8M
  • Last (time)
    4:00p ET 01/15/21
  • Last (size)
    30
  • 52-Wk Range
    14.01 - 99.95
    LowHigh
  • (03/16/20 - 01/08/21)
    23.82%
  • 90.8%
  • Market Cap
    4.8B
  • Shares Outstanding
    63.0M
  • -1.72
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.1
  • 79.43
  • (% of float 12/31/20)
    16.09

Latest News

January 15, 2021
5:45 pm ET
Zacks
January 11, 2021
6:05 am ET
Globe Newswire
6:02 am ET
Globe Newswire
6:00 am ET
Globe Newswire
January 08, 2021
7:50 am ET
MarketWatch
January 04, 2021
4:05 pm ET
Globe Newswire
December 17, 2020
4:05 pm ET
Globe Newswire
December 09, 2020
4:01 pm ET
Globe Newswire
December 05, 2020
10:00 am ET
Globe Newswire
November 10, 2020
4:01 pm ET
Globe Newswire
November 09, 2020
4:06 pm ET
Globe Newswire
9:00 am ET
Globe Newswire
November 05, 2020
4:17 pm ET
Accesswire
4:04 pm ET
Globe Newswire
October 29, 2020
4:06 pm ET
Globe Newswire
August 07, 2020
7:32 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.